Related Experiment Video
Updated: Jun 26, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked
M Perugini1, C H Kok, A L Brown
1Division of Haematology, Institute of Medical and Veterinary Science, Hanson Institute, Adelaide, South Australia, Australia.
Abstract:
The tumor suppressor Gadd45alpha was earlier shown to be a repressed target of sustained receptor-mediated ERK1/2 signaling. We have identified Gadd45alpha as a downregulated gene in response to constitutive signaling from two FLT3 mutants (FLT3-ITD and FLT3-TKD) commonly found in AML, and a leukemogenic GM-CSF receptor trans-membrane mutant (GMR-V449E). GADD45A mRNA downregulation is also associated with FLT3-ITD(+) AML. Sustained ERK1/2 signaling contributes significantly to receptor-mediated downregulation of Gadd45alpha mRNA in FDB1 cells expressing activated receptor mutants, and in the FLT3-ITD(+) cell line MV4;11. Knockdown of Gadd45alpha with shRNA led to increased growth and survival of FDB1 cells and enforced expression of Gadd45alpha in FDB1 cells expressing FLT3-ITD or GMR-V449E resulted in reduced growth and viability. Gadd45alpha overexpression in FLT3-ITD(+) AML cell lines also resulted in reduced growth associated with increased apoptosis and G(1)/S cell cycle arrest. Overexpression of Gadd45alpha in FDB1 cells expressing GMR-V449E was sufficient to induce changes associated with myeloid differentiation suggesting Gadd45alpha downregulation contributes to the maintenance of receptor-induced myeloid differentiation block. Thus, we show that ERK1/2-mediated downregulation of Gadd45alpha by sustained receptor signaling contributes to growth, survival and arrested differentiation in AML.
Insights
The tumor suppressor Gadd45alpha is downregulated in acute myeloid leukemia (AML) due to sustained receptor signaling, promoting cancer growth and survival. Restoring Gadd45alpha levels inhibits AML cell proliferation and induces differentiation.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Gadd45alpha, a tumor suppressor, is a known repressed target of sustained ERK1/2 signaling.
- Constitutive signaling from FLT3 mutants (FLT3-ITD, FLT3-TKD) and a GM-CSF receptor mutant (GMR-V449E) are common in AML.
- GADD45A mRNA downregulation correlates with FLT3-ITD(+) AML.
Purpose of the Study:
- To investigate the role of Gadd45alpha downregulation in AML pathogenesis.
- To determine the impact of sustained receptor signaling on Gadd45alpha expression.
- To evaluate the therapeutic potential of restoring Gadd45alpha function in AML.
Main Methods:
- Analyzing Gadd45alpha gene expression in AML cell lines with specific receptor mutants.
- Utilizing shRNA to knockdown Gadd45alpha and assessing effects on cell growth and survival.
- Enforcing Gadd45alpha expression and observing its impact on cell viability, apoptosis, and differentiation.
Main Results:
- Sustained ERK1/2 signaling significantly downregulates Gadd45alpha mRNA in cells with activated receptor mutants.
- Gadd45alpha knockdown enhances FDB1 cell growth and survival.
- Gadd45alpha overexpression reduces growth and viability in FLT3-ITD and GMR-V449E expressing cells, inducing apoptosis and cell cycle arrest.
- Gadd45alpha overexpression in GMR-V449E cells promotes myeloid differentiation, suggesting its downregulation maintains a differentiation block.
Conclusions:
- ERK1/2-mediated Gadd45alpha downregulation by sustained receptor signaling is a key mechanism driving AML growth, survival, and blocked differentiation.
- Restoring Gadd45alpha function presents a potential therapeutic strategy for AML.
Related Concept Videos
Abnormal Proliferation
TGF - β Signaling Pathway
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
